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The quest for immortality has long fascinated mankind. According to Greek mythology, ambrosia
was the elixir of gods, bestowing them with immortality. Alchemists sought the mystical philoso-
pher’s stone, and Oscar Wilde’s Dorian Gray bequeathed his soul to stop himself from growing
old. F. Scott Fitzgerald’s Benjamin Button was all too familiar with the term ‘‘reverse aging.’’ While
biblical sources refer to Methuselah, the man who lived close to a thousand years, in actuality, the
current record for longest human lifespan is 122 years. With global advances in medicine and
nutrition, humans today are indeed living longer than ever before. Over the last three decades,
studies from model organisms and centenarians have identified conserved signaling pathways
controlling longevity and healthspan. We have also made some progress in understanding the
genetics behind the beneficial effects of calorie restriction. Seemingly ageless organisms such
as hydra and planaria continue to pique our interest into the prospects of regenerative medicine
in humans. In this issue’s Select, we present some of the latest insights into the biology of aging.NF-kB-mediated hypothalamic inflam-
mation leads to systemic aging. Inhibit-
ing inflammation or administration of
GnRH promotes longevity. Image cour-
tesy of D. Cai.Mighty Mice Keep a Cool Head
Studies from invertebrate systems have unraveled roles for specific neurons associ-
ated with either nutrient sensing or insulin production in regulating organismal
physiology and lifespan. In mammals, the hypothalamus is a central regulator of
neuroendocrine processes such as growth and development. Zhang et al. find that
the levels of NF-kB, a transcriptional regulator of inflammation and immune signaling,
are markedly upregulated in the hypothalamus of aged mice. By systematically con-
trolling NF-kB activity in the hypothalamus alone, the authors are able to increase the
healthspan aswell as the lifespan ofmice. These effects are thought to bemediated at
least in part by increased proinflammatory signaling by hypothalamic microglia, as
mice lacking the NF-kB activator IKKB in microglia or neurons alone demonstrate
increased muscle function and cognitive fitness. An unexpected but fascinating
finding that stems from their study is the role of NF-kB in suppressing the expression
of gonadotropin-releasing hormone (GnRH), a hypothalamic hormone regulating the
production of sex hormones. Administration of GnRH in the hypothalamus was found
to promote adult neurogenesis, and peripheral administration led to improvements inthe healthspan of mice expressing elevated NF-kB activity. Remarkably, these effects of GnRH are thought to be independent
of its regulation of sex hormone levels. The study hence provides two fundamentally new insights in that inflammatory
signaling in the hypothalamus can control systemic aging and at least some aspects of age-associated decline can be amelio-
rated through GnRH treatment. Mechanistic insights into how GnRH drives these beneficial effects are yet to be determined,
as are the effects of other NF-kB targets in modulating lifespan.
Zhang, G., et al. (2013). Nature 497, 211–216.(Left) A mouse model of progeria.
(Right) A progeric sibling with a hypo-
morphic allele of ICMT. Image courtesy
of M.O. Bergo.Regressing Progeria
Hutchinson-Gilford Progeria syndrome (HGPS) is a rare genetic disorder marked by
accelerated aging-like symptoms. Patients with HGPS are presented with limited
therapeutic options, with the majority barely surviving beyond their teenage years.
HGPS is primarily caused bymutations in the lamin A gene that results in the formation
of a truncated form of prelamin A that cannot be processed to mature lamin
A. Prelamin A interfereswith nuclear structure and function, andHGPSpatients exhibit
abnormally shaped ‘‘blebbed’’ nuclei. The C terminus of prelamin A is posttranslation-
ally modified through farnesylation and subsequent methylation. Though blocking
farnesylation hasbeen shown to reverse the abnormal nuclearmorphology associated
with HGPS, it has had limited effects on reversing the various other symptoms and
short lifespan of animal models as well as patients, exemplified by a recently
concluded clinical trial. A new study from Ibrahim and colleagues investigates the
effect of targeting prelamin A methylation in a mouse model of HGPS, using a
hypomorphic allele of the methyltransferase ICMT. Targeting methylation resulted inCell 154, July 3, 2013 ª2013 Elsevier Inc. 5
a dramatic improvement in growth, body weight, bone fractures, and also prolonged lifespan. Reducing prelamin A
methylation was found to increase Akt/mTOR signaling but remarkably had little effect on correcting the misshapen nuclei.
A recent study identified a role for themTOR inhibitor rapamycin in reversing the nuclear blebbing of the cells of HGPSpatients,
but rapamycin was found to have little effect in this case. Whether HGPS truly provides insights into normal aging has been a
point of contention, but the results from Ibrahim et al. provide a promising new therapeutic candidate for what is clearly a
debilitating disorder.
Ibrahim, M.X., et al. (2013). Science 340, 1330–1333.Chromosomes (blue) have short telo-
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mutant with increased activity. Image
courtesy of I. Simeonova and F. Toledo.To p53 or Not p53
As the guardian of the genome, p53 is a likely contender for the title of most-famous
protein. Insights into p53’s roles have diversified over the years, ranging from the
regulation of metabolism to neurodegeneration. With regards to aging, however,
the role of p53 has been quite paradoxical. Constitutive expression of p53 confers
remarkable cancer resistance but at the same time leads to accelerated aging-like
symptoms and premature death, with the latter thought to be a consequence of
excessive senescence and cell death. Following up on these observations, Simeo-
nova et al. find that mutant mice expressing elevated p53 function by virtue of
lacking p53’s C-terminal domain suffer a number of debilitating symptoms, including
aplastic anemia, cardiac hypertrophy, and pulmonary fibrosis. These symptoms are
hallmarks of human syndromes caused by short telomeres. Consistent with this, the
authors identified significant reductions in telomere length as well as genes involved
in telomere metabolism in the mutant mice, thereby not only identifying a new role for
p53, but also clarifying the surprising effects associated with a gain in its activity.
Telomere attrition has long been correlated with increased age, but whether it
is truly causative or presents a point of therapeutic intervention remains to be
elucidated.Simeonova, I., et al. (2013). Cell Rep. Published online June 13, 2013. http://dx.doi.org/10.1016/j.celrep.2013.05.028.
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